Tag: Vaccines
RSVpreF Vaccine Found to Be Safe, Effective During Pregnancy
Phase 3 trial shows the vaccine is effective against medically attended severe RSV-associated lower respiratory tract illness in infants
WHO: Healthy Children, Teens May Not Need More COVID-19 Shots
Instead, COVID-19 vaccines should go to high-risk people, according to the agency's Strategic Advisory Group of Experts on Immunization
Electronic Reminders Boost Flu Vaccine Uptake in Older Adults
Letters highlighting potential cardiovascular benefits of influenza vaccination found to be particularly effective
Benefits of Maternal Immunization Against Group B Strep Explored
Net monetary benefit from group B Streptococcus vaccination estimated to range from $1.1 to $17 billion
Antibody Response Prolonged With COVID-19 Vaccine-Associated Symptoms
Increased likelihood of experiencing prolonged neutralizing antibody response seen for those with vaccine-associated symptoms, prior SARS-CoV-2 infection
Age, Cancer Type Affect COVID-19 Vaccine Uptake in Cancer Patients
Higher rates of vaccination seen in older patients; lower rates seen for metastatic solid tumors, with comorbidities
Axillary Lymphadenopathy Resolves at Mean 102 Days After COVID-19 Booster
No significant associations seen for age, vaccine booster type, history of breast cancer with time to resolution
ACC: COVID-19 Vaccination Cuts Risk for Cardiac Events With SARS-CoV-2 Infection
Findings significant for both partial and complete COVID-19 vaccination
FDA Panel Backs Second RSV Vaccine for Older Americans
In two-part vote, panel voted 10 to 2 in favor of the vaccine's safety and unanimously on the shot's effectiveness
FDA Panel Backs Pfizer RSV Vaccine for Older Americans
Pfizer has reported that its vaccine would reduce risk from RSV by as much as 86 percent
